Know Cancer

or
forgot password

A Prospective Multicenter Randomized Controlled Clinical Trial to Compare the Method of Protective Diverting Loop Ileostomy With or Without the Support of a Plastic Rod


N/A
18 Years
N/A
Open (Enrolling)
Both
Ileostomy, Rectal Neoplasms

Thank you

Trial Information

A Prospective Multicenter Randomized Controlled Clinical Trial to Compare the Method of Protective Diverting Loop Ileostomy With or Without the Support of a Plastic Rod


Background

For rectal anastomoses within 6 cm of the anal verge, leakage rates are up to 15%. Here
liberal use of protective stomas is widely accepted. Fecal diversion by loop ostomy may also
be performed after extended adhesiolysis with serosal lesions and risk of intestinal
perforation, in patients with obstructing rectal tumours requiring neoadjuvant
radio-chemotherapy or in patients with complex anorectal injuries or fistulas. Generally,
diverting loop ileostomies are secured at skin level by means of a supporting device in
order to prevent retraction of the loop ileostomy into the abdomen. Nevertheless, due to the
supporting rod, difficulties may occur in applying a stoma bag correctly and leakage of
feces onto the skin may occur even with correct eversion of the afferent limb. Despite
easier application of stoma bags and therefore reduced risk of skin irritation, none of
these alternative techniques are established. In various non-randomized studies rodless loop
ileostomies were described with an overall morbidity between 3 and 39%. However definition
of morbidity varies significantly in these studies and randomised controlled trials are
missing so far.

Objective

The aim of this study is to determine, whether a modification (without rod) of the current
standard method of protective loop ileostomy formation (with rod) could improve ileostomy
specific morbidity. Secondary endpoints include stoma care, determinants of quality of life
and stoma function.

Methods

The study is designed as multi-institutional, randomized controlled, two-armed study.
Patients scheduled for a protective loop ileostomy and meeting the eligibility criteria will
be randomized to creation of a loop ileostomy with or without sustaining rod.


Inclusion Criteria:



- patients scheduled for planned protective loop ileostomy

Exclusion Criteria

- patients with long-term use of corticosteroids (> 15 mg prednisolone equivalent)

- immunosuppressive agent rapamune

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Severe stoma specific morbidity rate

Outcome Time Frame:

postoperative during 2 weeks, 3 months postoperative

Safety Issue:

No

Principal Investigator

Lukas E Bruegger, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Bern University Hospital,Dep. of Visceral and Transplant Surgery Switzerland

Authority:

Switzerland: Ethikkommission

Study ID:

061/08

NCT ID:

NCT00959738

Start Date:

August 2008

Completion Date:

December 2012

Related Keywords:

  • Ileostomy
  • Rectal Neoplasms
  • loop ileostomy
  • quality of life
  • morbidity
  • Rectal Neoplasms
  • Neoplasms
  • Rectal Neoplasms

Name

Location